Oppenheimer downgrades Freshpet on turnaround uncertainty after slow start to year

Investing.com
12 Mar

Investing.com -- Oppenheimer downgraded Freshpet Inc (NASDAQ:FRPT) to "Perform" from "Outperform," citing a weaker-than-expected start to the year and more cautious management commentary. The firm believes investors should wait for clearer signs of revenue stabilization before considering a potential turnaround.

“We now find it harder to call a bottom in shares and view the risk/reward as balanced,” analyst said as it removed the previous $140 price target.

Oppenheimer has also trimmed its sales estimates for Freshpet, now expecting full-year growth to align with first-quarter trends.

The firm noted that Freshpet shares have historically bottomed at around three times price-to-sales, which could suggest further downside into the $70 range. Given recent momentum at Chewy (NYSE:CHWY), Oppenheimer now views the pet retailer more favorably than Freshpet in the near term.

Despite the downgrade, Oppenheimer still considers Freshpet a potential acquisition target over the longer term.

However, in the current market environment, where investors are shifting away from high-risk names, the firm sees limited upside in the stock.

Freshpet was also removed from Oppenheimer’s top consumer staples picks, which now include more defensive names such as Church&Dwight (NYSE:CHD), Prestige Consumer Healthcare, and Walmart (NYSE:WMT), as well as discretionary stocks like Target and Ulta Beauty (NASDAQ:ULTA).

Although Freshpet has long-term growth drivers, including product innovation, household penetration, and global expansion, Oppenheimer sees near-term challenges.

With disappointing guidance at the recent Consumer Analyst Group of New York (CAGNY) conference and a more cautious tone from management, the firm believes it is prudent to take a wait-and-see approach before expecting a reacceleration in sales.

Related Articles

Oppenheimer downgrades Freshpet on turnaround uncertainty after slow start to year

Puma sees quarterly sales drop on US, China performance

US agency recommends restrictions on helicopters after Washington mid-air collision

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10